Epizyme reported $77.42M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Abbott ABT:US $ 7675M 2124M
Agios Pharmaceuticals AGIO:US $ 80.03M 123.1M
Amarin AMRN:US $ 219.15M 0.3M
Amgen AMGN:US $ 6528M 1461M
Avrobio Inc AVRO:US $ 161.66M 27.9M
Biogen BIIB:US $ 1749.3M 512.1M
Bluebird Bio BLUE:US $ 106.26M 54.9M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Daiichi Sankyo 4568:JP Y 662477M 85182M
Eisai 4523:JP Y 309633M 51213M
Epizyme EPZM:US $ 77.42M 20.92M
Exelixis EXEL:US $ 723.27M 76.1M
Gilead Sciences GILD:US $ 4296M 1042M
GlaxoSmithKline GSK:LN 10967M 6693M
Glaxosmithkline GSK:US $ 10967M 6693M
IONIS PHARMACEUT IONS:US $ 542.51M 326.68M
Karyopharm Therapeutics KPTI:US $ 153.26M 37.2M
Macrogenics MGNX:US $ 47.33M 76.14M
Merk MRK:US $ 8556M 460M
Mirati Therapeutics MRTX:US $ 293.42M 100.32M
Novartis NOVN:VX SF 13852M 1445M
Novartis NVS:US $ 13852M 1445M
Pfizer PFE:US $ 2470M 526M
Regeneron Pharmaceuticals REGN:US $ 3345.7M 460.1M
Seattle Genetics SGEN:US $ 261M 163.84M
Spectrum Pharmaceuticals SPPI:US $ 78.68M 9.86M
Vertex Pharmaceuticals VRTX:US $ 7600.1M 805.1M
Xencor XNCR:US $ 78.27M 65.21M